Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Fareed

Showing results (191-200 of 384) with videos related to

Pageof 39
Sort By:
Seminars in Thrombosis and Hemostasis|April 1, 1991
Neutralization of recombinant hirudin: some practical considerationsJ Fareed, J M Walenga, D Hoppensteadt, et al.
Thrombosis Research|December 1, 1991
In vitro studies on thrombin generation in citrated, r-hirudinized and heparinized whole bloodB Kaiser, J Fareed, J M Walenga, et al.
Annals of the New York Academy of Sciences|January 1, 1989
In vitro studies of the interaction of heparin, low molecular weight heparin and heparinoids with plateletsH L Messmore, B Griffin, J Fareed, et al.
Archives of Surgery (Chicago, Ill. : 1960)|October 1, 1986
Effect of heparin and heparin fractions on experimental abscess formationR A Prinz, Z Shuber, J Fareed, et al.
The American Journal of Cardiology|September 16, 1998
Low-molecular-weight heparins: pharmacologic profile and product differentiationJ Fareed, W Jeske, D Hoppensteadt, et al.
Seminars in Thrombosis and Hemostasis|November 5, 1999
Preclinical biochemistry and pharmacology of low molecular weight heparins in vivo--studies of venous and arterial thrombosisB Kaiser, C M Kirchmaier, H K Breddin, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1995
Pharmacologic validation of the clinical effects of an optimized low-molecular-weight heparin-reviparinJ Fareed, W Jeske, V Eschenfelder, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1993
In vivo study of bleeding and antithrombotic effects of low molecular weight heparin ML-009723K Malinowska, O Iqbal, D A Hoppensteadt, et al.
The Journal of Cardiovascular Surgery|November 1, 1992
Pre- vs postoperative pharmacologic inhibition of platelets: effect on intimal hyperplasia in canine autogenous vein graftsP B Dobrin, J Golan, J Fareed, et al.
Thrombosis Research|April 27, 2001
Inhibition of tissue factor-activated platelets by low-molecular-weight heparins and glycoprotein IIb/IIIa receptor antagonistS Ahmad, W P Jeske, Q Ma, et al.
Pageof 39

Showing results (191-200 of 384) with videos related to

Sort By:
Pageof 39
Seminars in Thrombosis and Hemostasis|April 1, 1991
Neutralization of recombinant hirudin: some practical considerationsJ Fareed, J M Walenga, D Hoppensteadt, et al.
Thrombosis Research|December 1, 1991
In vitro studies on thrombin generation in citrated, r-hirudinized and heparinized whole bloodB Kaiser, J Fareed, J M Walenga, et al.
Annals of the New York Academy of Sciences|January 1, 1989
In vitro studies of the interaction of heparin, low molecular weight heparin and heparinoids with plateletsH L Messmore, B Griffin, J Fareed, et al.
Archives of Surgery (Chicago, Ill. : 1960)|October 1, 1986
Effect of heparin and heparin fractions on experimental abscess formationR A Prinz, Z Shuber, J Fareed, et al.
The American Journal of Cardiology|September 16, 1998
Low-molecular-weight heparins: pharmacologic profile and product differentiationJ Fareed, W Jeske, D Hoppensteadt, et al.
Seminars in Thrombosis and Hemostasis|November 5, 1999
Preclinical biochemistry and pharmacology of low molecular weight heparins in vivo--studies of venous and arterial thrombosisB Kaiser, C M Kirchmaier, H K Breddin, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1995
Pharmacologic validation of the clinical effects of an optimized low-molecular-weight heparin-reviparinJ Fareed, W Jeske, V Eschenfelder, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1993
In vivo study of bleeding and antithrombotic effects of low molecular weight heparin ML-009723K Malinowska, O Iqbal, D A Hoppensteadt, et al.
The Journal of Cardiovascular Surgery|November 1, 1992
Pre- vs postoperative pharmacologic inhibition of platelets: effect on intimal hyperplasia in canine autogenous vein graftsP B Dobrin, J Golan, J Fareed, et al.
Thrombosis Research|April 27, 2001
Inhibition of tissue factor-activated platelets by low-molecular-weight heparins and glycoprotein IIb/IIIa receptor antagonistS Ahmad, W P Jeske, Q Ma, et al.
Pageof 39